Home › Funds › Defilade Capital Management, L.P. › SOLV

Defilade Capital Management, L.P. position in SOLV

SOLVENTUM CORP · Health Care

Defilade Capital Management, L.P. reported holding 316,454 shares of SOLV (SOLVENTUM CORP) in its Q2 2026 13F filing — a position valued at US$24.4M, representing 3.27% of its reported portfolio and ranking #13 among its reported holdings. Defilade Capital Management, L.P. first reported this position in Q2 2026.

Latest position (Q2 2026)316.45K sh
Reported value held$24.41M
Portfolio Weight3.27%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Defilade Capital Management, L.P.'s SOLV position evolved

Defilade Capital Management, L.P. first disclosed a stake in SOLV in Q2 2026 at 316,454 shares (US$24.4M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 316.45K $24.41M New

About SOLV and 13F data

SOLV (SOLVENTUM CORP) is a Health Care company. 45 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.25B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$486.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →

FAQ

How long has Defilade Capital Management, L.P. held SOLV?

Defilade Capital Management, L.P. has disclosed SOLV holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Defilade Capital Management, L.P.'s current position in SOLV?

As of Q2 2026, Defilade Capital Management, L.P. holds 316.45K shares of SOLV (SOLVENTUM CORP), valued at $24.41M, representing 3.27% of its reported portfolio and ranking #13.

Has Defilade Capital Management, L.P. been buying or selling SOLV?

In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. newly opened its position in SOLV.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.